ScreenCell® logo
Devis Rapide

Kit MB

ScreenCell MB kit
En savoir plus
Demander un devis

Tant de raisons d’utiliser le kit MB dans vos projets

4 applications en biologie moléculaire et en culture cellulaire.
Le kit MB est certifié CE et conçu pour un usage clinique de routine.
Un taux de recouvrement supérieur à 90 %.
Permet de filtrer jusqu'à 18 ml de sang total.
Délai d'utilisation de l'échantillon :
4 heures après le prélèvement.
Travailler sur des cellules tumorales circulantes vivantes en suspension.

Parce que des chiffres valent mieux que des mots

Les caractéristiques du kit MB

Un éventail d'applications
à votre disposition

Extraction d'ADN

Extraction d'ARN

Single Cell Sequencing

Culture cellulaire 2D

Culture cellulaire 3D

kit MB

Les écrits restent,
les paroles s'envolent

Imprégnez-vous des articles scientifiques rédigés par nos clients et partenaires, qui ont utilisé le kit CYTO dans leurs recherches et témoignent de son efficacité.

Cancer du poumon

An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer

Objectives Circulating tumour cells (CTCs) are reported to be predictive for prognosis and response to treatment in advanced lung cancer....
Learn more
Adénocarcinome œsophagien

Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus – Cytomorphological Heterogeneity

Introduction: Esophageal adenocarcinoma (EAC) often recurs systemically despite therapy with a curative aim. New diagnostic and therapeutic approaches are urgently...
Learn more
Cancer de la vessie

Cytomorphologic visualization of circulating tumor cells in urinary bladder cancer patients using ScreenCell™ technology: Potential as a simple cytology test

Circulating tumor cells (CTC) are a recent technique which is a potentially important prognostic factor in many solid tumors. There...
Learn more
Cancer de la prostate

Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer

Selecting a well-suited method for isolating/characterizing circulating tumor cells (CTCs) is challenging. Evaluating sensitive and specific markers for prostate cancer...
Learn more
Cancer du sein

Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients

Background: Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase...
Learn more
Cancer du sein

Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients

Circulating tumor cells have a strong potential as a quasi-non-invasive tool for setting up a precision medicine strategy for cancer...
Learn more
Biopsie liquide

A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance.

Liquid biopsies represent a valid alternative to conventional tissue biopsies, offering a real time molecular picture of tumors in a...
Cancer de la vessie

The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer

Cancer de la prostate

Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer

Selecting a well-suited method for isolating/characterizing circulating tumor cells (CTCs) is challenging. Evaluating sensitive and specific markers for prostate cancer...
Cancer colorectal

Détection des mutations RAS dans les cellules tumorales circulantes : applications au cancer colorectal et perspectives

Les mutations somatiques présentes dans les gènes RAS (KRAS et NRAS) sont largement associées à l’absence de réponse aux traitements...
Cancer du sein

Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology

A challenge for circulating tumor cell (CTC)-based diagnostics is the development of simple and inexpensive methods that reliably detect the...
Cancer colorectal

Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery

In colorectal cancer (CRC), KRAS mutations are a strong negative predictor for treatment with the EGFR-targeted antibodies cetuximab and panitumumab....
Preuve de concept

A new device for rapid isolation by size and characterization of rare circulating tumor cells

Background: Circulating tumor cells (CTCs) likely derive from clones in the primary tumor, suggesting that they can be used for...
Voir plus d'articles
Pour l'amélioration de la
prise en charge des patients
grâce à l'analyse des CTC
Demander un devis
Demander la brochure
ScreenCell MBSB kit

Caractéristiques et performances du kit MBSB.

Capacités

0 ml

Le kit MB permet de filtrer jusqu’à 18 ml de sang total.

Délai de filtration

0 jours

L’isolement des CTC peut être réalisé jusqu’à 3 jours suivant le prélèvement sanguin.